go back

Urine Two-Gene Prostate Cancer Risk Test

Nebraska rates for HCPCS 0339U

Helps judge whether a man is likely to have prostate cancer serious enough to need a biopsy. The activity of two genes, HOXC6 and DLX1, is measured in a urine sample collected straight after a digital rectal examination, and the result is reported as a probability.

Rates data updated July 2026.

Facilitymedian $1,175 · 10th–90th $537$2,2390%10%20%10th90th$1,175Professionalmedian $501 · 10th–90th $457$1,4450%20%40%10th90th$501$500.0$1.0K$2.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$537.03
Median
$1,995.26
Typical High
$3,801.89
Aetna
Setting
Professional
Modifier
Global
Typical Low
$501.19
Median
$501.19
Typical High
$501.19
BCBS
Setting
Facility
Modifier
Global
Typical Low
$891.25
Median
$1,148.15
Typical High
$2,238.72
BCBS
Setting
Professional
Modifier
Global
Typical Low
$1,096.48
Median
$1,174.90
Typical High
$1,258.93
Cigna
Setting
Professional
Modifier
Global
Typical Low
$912.01
Median
$1,445.44
Typical High
$1,819.70
Medica
Setting
Facility
Modifier
Global
Typical Low
$501.19
Median
$1,148.15
Typical High
$3,630.78
Medica
Setting
Professional
Modifier
Global
Typical Low
$316.23
Median
$457.09
Typical High
$2,187.76
Midlands
Setting
Professional
Modifier
Global
Typical Low
$912.01
Median
$912.01
Typical High
$912.01
United
Setting
Facility
Modifier
Global
Typical Low
$457.09
Median
$758.58
Typical High
$912.01
United
Setting
Professional
Modifier
Global
Typical Low
$436.52
Median
$457.09
Typical High
$2,089.30